Your browser doesn't support javascript.
loading
SARS-CoV-2-derived fusion inhibitor lipopeptides exhibit highly potent and broad-spectrum activity against divergent human coronaviruses.
Zhu, Yuanmei; Yu, Danwei; Hu, Yue; Wu, Tong; Chong, Huihui; He, Yuxian.
Afiliação
  • Zhu Y; NHC Key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Yu D; NHC Key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Hu Y; NHC Key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Wu T; NHC Key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Chong H; NHC Key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • He Y; NHC Key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. yhe@ipb.pumc.edu.cn.
Signal Transduct Target Ther ; 6(1): 294, 2021 08 03.
Article em En | MEDLINE | ID: mdl-34344868

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Infecções por Coronavirus / Internalização do Vírus / Lipopeptídeos / Coronavírus da Síndrome Respiratória do Oriente Médio / SARS-CoV-2 / COVID-19 / Tratamento Farmacológico da COVID-19 Limite: Humans Idioma: En Revista: Signal Transduct Target Ther Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Infecções por Coronavirus / Internalização do Vírus / Lipopeptídeos / Coronavírus da Síndrome Respiratória do Oriente Médio / SARS-CoV-2 / COVID-19 / Tratamento Farmacológico da COVID-19 Limite: Humans Idioma: En Revista: Signal Transduct Target Ther Ano de publicação: 2021 Tipo de documento: Article